Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
BMC Pharmacology & Toxicology|January 3, 2024
Prediction of drug-drug interactions between roflumilast and CYP3A4/1A2 perpetrators using a physiologically-based pharmacokinetic (PBPK) approachGuangwei Jia, Congcong Ren, Hongyan Wang, et al.
Clinical Breast Cancer|January 13, 2023
In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer CellsZhongji Zhang, Fengbo Li, Yan Li, et al.
Medicine|December 5, 2023
Peripheral blood inflammatory indexes in breast cancer: A reviewJiaqiang Xie, Zhenxi Guo, Yijing Zhu, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 14, 2009
Novel zwitterionic-polymer-coated silica nanoparticlesGuangwei Jia, Zhiqiang Cao, Hong Xue, et al.
Cytokine|April 21, 2022
Crocin attenuates NF-κB-mediated inflammation and proliferation in breast cancer cells by down-regulating PRKCQQuanxiao Xu, Jinsong Yu, Guangwei Jia, et al.
Chemical Biology & Drug Design|April 25, 2024
Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expressionYunhao Jia, Han Yang, Jinsong Yu, et al.
Pathology, Research and Practice|August 9, 2023
Clinical importance and PI3K/Akt pathway-dependent anti-proliferative role of PALMD and DPT in breast cancerYang Su, Yan Du, Shouwan Ye, et al.
Pathology, Research and Practice|October 7, 2021
The effects of hsa_circ_0000517/miR-326 axis on the progression of breast cancer cells and the prediction of miR-326 downstream targets in breast cancerJinsong Yu, Fengbo Li, Yan Li, et al.
Toxicology and Applied Pharmacology|January 27, 2022
Crocin induces ROS-mediated papillary thyroid cancer cell apoptosis by modulating the miR-34a-5p/PTPN4 axis in vitroYan Tang, Han Yang, Jinsong Yu, et al.
Environmental Toxicology|July 29, 2021
circZFR regulates thyroid cancer progression by the miR-16/MAPK1 axisHui Xiong, Huimei Yu, Guangwei Jia, et al.
Pageof 2